Search

everythinglearnresearchcommunity

for

Search:↓

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Neurotrophin-4 increases calcium current in specific mouse neurons through the PI3K pathway.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Two distinct pathways direct proteins to vacuoles in Arabidopsis, affecting root hair growth and protein targeting.

TCDD changes skin cell growth and keratin production in mice.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

The enzyme is crucial for skin cell development and can be activated without proteolytic activation.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

VDDR I and II are genetic disorders affecting vitamin D use, causing rickets, with VDDR I treatable by vitamin D supplements and VDDR II needing high doses and calcium.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

A new taurine-based liquid can help treat hair loss by improving hair follicle health and promoting regrowth.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tay syndrome is a unique genetic disorder causing skin, hair, and developmental issues.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The hydrogel helps heal diabetic wounds by reducing infection and inflammation.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.